Your browser doesn't support javascript.
loading
Balancing benefits and risks in the era of biologics.
Adami, Giovanni; Saag, Kenneth G; Chapurlat, Roland D; Guañabens, Nuria; Haugeberg, Glenn; Lems, Willem F; Matijevic, Radmila; Peel, Nicola; Poddubnyy, Denis; Geusens, Piet.
Afiliação
  • Adami G; Rheumatology Unit, University of Verona, Pz Scuro 10, 37135, Verona, Italy.
  • Saag KG; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Chapurlat RD; INSERM UMR 1033, Université de Lyon, Hôpital E Herriot, Lyon, France.
  • Guañabens N; Rheumatology Department, Hospital Clinic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Haugeberg G; Division of Rheumatology, Medicine Department, Southern Hospital Trust, Trondheim, Norway.
  • Lems WF; Amsterdam UMC, location VUmc, Amsterdam, the Netherlands.
  • Matijevic R; University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia.
  • Peel N; Metabolic Bone Centre, Northern General Hospital Sheffield, UK.
  • Poddubnyy D; Department of Gastroenterology, Infectious Diseases, and Rheumatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Geusens P; CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, the Netherlands.
Ther Adv Musculoskelet Dis ; 11: 1759720X19883973, 2019.
Article em En | MEDLINE | ID: mdl-31695755

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Musculoskelet Dis Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Musculoskelet Dis Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido